Standout Papers

Review of Indications of FDA-Approved Immune Checkpoint Inhibitors p... 2017 2026 2020 2023 859
  1. Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence (2020)
    Raju Vaddepally, Prakash Kharel et al. Cancers
  2. Current Diagnosis and Management of Immune Related Adverse Events (irAEs) Induced by Immune Checkpoint Inhibitor Therapy (2017)
    Vivek Kumar, Neha Chaudhary et al. Frontiers in Pharmacology

Immediate Impact

2 by Nobel laureates 5 from Science/Nature 65 standout
Sub-graph 1 of 20

Citing Papers

Senescent glia link mitochondrial dysfunction and lipid accumulation
2024 StandoutNature
Principles and therapeutic applications of adaptive immunity
2024 Standout
2 intermediate papers

Works of Abhinav Chandra being referenced

Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence
2020 Standout

Author Peers

Author Last Decade Papers Cites
Abhinav Chandra 604 1188 289 474 85 2.5k
Juhee Song 371 622 783 314 157 2.7k
Stefania Galimberti 280 448 254 260 104 2.6k
Andrew Wilson 623 463 682 283 77 2.9k
June M. McKoy 350 483 506 281 47 2.2k
Tiepu Liu 922 399 610 206 52 2.8k
Tineke J. Smilde 296 621 615 219 69 2.2k
Moreno Tresoldi 592 370 311 282 78 2.9k
Daniela Tomasoni 1161 424 299 576 83 3.1k
L. Grunebaum 548 691 528 258 81 3.7k
Julie Vincent 480 1270 605 1124 78 3.2k

All Works

Loading papers...

Rankless by CCL
2026